Open Access772 Long-Term Mucosal Healing, Clinical Response and Clinical Remission in Patients With Ulcerative Colitis Treated With the Anti-MAdCAM-1 Antibody Ontamalimab: Results From the Open-Label Extension Study TURANDOT II
Author(s) -
Silvio Danese,
William J. Sandborn,
Walter Reinisch,
Xavier Hébuterne,
Maria Kłopocka,
Dino Tarabar,
Tomáš Vaňásek,
Miloš Greguš,
Paul Hellstern,
Sang Woo Kim,
Miles Sparrow,
Kenneth J. Gorelick,
Martina Goetsch,
Caleb Bliss,
Charu Gupta,
Fabio Cataldi,
Séverine Vermeire
Publication year - 2019
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000592624.44779.ee
Subject(s) - medicine , ulcerative colitis , addressin , gastroenterology , placebo , clinical endpoint , clinical trial , surgery , pathology , disease , integrin , receptor , alternative medicine